An effusion of blood and phlegmon secondary to anakinra injection.
Ortiz
Arisa E
AE
Fulwider
Cole M
CM
Wu
Jashin J
JJ
D018501:Antirheumatic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D015535:Arthritis, Psoriatic / Q000188:drug therapy; D002481:Cellulitis / Q000139:chemically induced* / Q000473:pathology / Q000628:therapy; D004653:Empyema / Q000139:chemically induced* / Q000473:pathology / Q000628:therapy; D006801:Humans; D007279:Injections, Subcutaneous; D053590:Interleukin 1 Receptor Antagonist Protein / Q000008:administration & dosage / Q000009:adverse effects*; D008297:Male; D008875:Middle Aged
D018501:Antirheumatic Agents; D053590:Interleukin 1 Receptor Antagonist Protein